These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31832989)

  • 1. Benzoxazines as new human topoisomerase I inhibitors and potential poisons.
    Foto E; Özen Ç; Zilifdar F; Tekiner-Gülbaş B; Yıldız İ; Akı-Yalçın E; Diril N; Yalçın İ
    Daru; 2020 Jun; 28(1):65-73. PubMed ID: 31832989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
    Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
    Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.
    Park S; Thapa Magar TB; Kadayat TM; Lee HJ; Bist G; Shrestha A; Lee ES; Kwon Y
    Eur J Med Chem; 2017 Feb; 127():318-333. PubMed ID: 28068603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase I poisons and suppressors as anticancer drugs.
    Bailly C
    Curr Med Chem; 2000 Jan; 7(1):39-58. PubMed ID: 10637356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A solid phase assay for topoisomerase I interfacial poisons and catalytic inhibitors.
    Cyril V; Muller MT
    Anal Biochem; 2012 Feb; 421(2):607-16. PubMed ID: 22214881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.
    Yao BL; Mai YW; Chen SB; Xie HT; Yao PF; Ou TM; Tan JH; Wang HG; Li D; Huang SL; Gu LQ; Huang ZS
    Eur J Med Chem; 2015 Mar; 92():540-53. PubMed ID: 25599951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.
    Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
    Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel securinine derivatives as topoisomerase I based antitumor agents.
    Hou W; Wang ZY; Peng CK; Lin J; Liu X; Chang YQ; Xu J; Jiang RW; Lin H; Sun PH; Chen WM
    Eur J Med Chem; 2016 Oct; 122():149-163. PubMed ID: 27344492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors.
    Yu X; Zhang M; Annamalai T; Bansod P; Narula G; Tse-Dinh YC; Sun D
    Eur J Med Chem; 2017 Jan; 125():515-527. PubMed ID: 27689733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
    Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
    Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,4-Diaryl-5,6-dihydro-1,10-phenanthroline and 2,4-diaryl-5,6-dihydrothieno[2,3-h] quinoline derivatives for topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
    Thapa P; Karki R; Yoo HY; Park PH; Lee E; Jeon KH; Na Y; Cho WJ; Kwon Y; Lee ES
    Bioorg Chem; 2012 Feb; 40(1):67-78. PubMed ID: 22000119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Fluorescence-Based Assay for Identification of Bacterial Topoisomerase I Poisons.
    Annamalai T; Cheng B; Keswani N; Tse-Dinh YC
    Methods Mol Biol; 2018; 1703():259-268. PubMed ID: 29177747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylstibonic acids: novel inhibitors and activators of human topoisomerase IB.
    Kim H; Cardellina JH; Akee R; Champoux JJ; Stivers JT
    Bioorg Chem; 2008 Aug; 36(4):190-7. PubMed ID: 18508107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic curvature in duplex DNA inhibits Human Topoisomerase I.
    Yang Z; Li D; Guo J; Shao F; Li T
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1322-5. PubMed ID: 22227211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase 1B poisons: Over a half-century of drug leads, clinical candidates, and serendipitous discoveries.
    Cinelli MA
    Med Res Rev; 2019 Jul; 39(4):1294-1337. PubMed ID: 30456874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity.
    Oppegard LM; Delgado JL; Kulkarni CA; Towle TR; Hart DE; Williams BP; Lentz SRC; Norris BJ; Flory CM; Schumacher RJ; Murry DJ; Kerns RJ; Hiasa H
    Invest New Drugs; 2019 Apr; 37(2):378-383. PubMed ID: 30198058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iridoids as DNA topoisomerase I poisons.
    Gálvez M; Martín-Cordero C; Ayuso MJ
    J Enzyme Inhib Med Chem; 2005 Aug; 20(4):389-92. PubMed ID: 16206835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human DNA topoisomerase IB by a cyclometalated gold III compound: analysis on the different steps of the enzyme catalytic cycle.
    Castelli S; Vassallo O; Katkar P; Che CM; Sun RW; Desideri A
    Arch Biochem Biophys; 2011 Dec; 516(2):108-12. PubMed ID: 22033340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I.
    Champoux JJ
    Ann N Y Acad Sci; 2000; 922():56-64. PubMed ID: 11193925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.